ArticleThe journal of allergy and clinical immunology. In practice2025
Hepatic Manifestations in Common Variable Immunodeficiency Associated With Mortality and Worse Hospital Outcomes in Nationwide Analysis Using National Readmission Database.
Article in The journal of allergy and clinical immunology. In practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Liver Disease in Common Variable Immunodeficiency: Current Evidence and Knowledge Gaps.International journal of molecular sciences · 2026Review
- Non-invasive assessment of hepatic involvement in common variable immunodeficiency and agammaglobulinemia using enhanced liver fibrosis score and shearwave elastography.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundLiver disease is associated with increased mortality in patients with common variable immunodeficiency (CVID), yet we lack population-level data on its impact on CVID-associated hospitalizations in the United States.
objectiveTo conduct a nationwide analysis evaluating the prevalence, spectrum, clinical correlates, and outcomes of hepatic manifestations among admitted adults with CVID.
methodsWe performed a retrospective cross-sectional analysis using the National Readmission Database, part of the Healthcare Cost and Utilization Project by the Agency for Healthcare Research and Quality. International Classification of Diseases, Tenth Revision codes were used to assess hepatic complications, comorbidities, risk factors, and outcomes in CVID-associated admissions with liver involvement.
resultsOf 181,288 CVID-related index hospitalizations, 10% (18,823) had a codiagnosed hepatic complication, specifically hepatic steatosis (38%), cirrhosis (24%), nonalcoholic fatty liver disease (17%), portal hypertension (15%), and nodular regenerative hyperplasia (14%). CVID-associated admissions with hepatic disease had longer median lengths of stay (7 vs 5 days, P < .0001), higher in-hospital mortality (11% vs 4%, P < .0001), and higher median hospital charges ($68,114 vs $44,757, P < .0001). They also had a higher prevalence of hypertension, chronic kidney disease, diabetes, obesity, and autoimmune cytopenia (P < .0001 for all). Alcohol use, hepatitis C, and hepatitis B were strong predictors of hepatic manifestations in CVID admissions (P < .0001). Patients with CVID with nodular regenerative hyperplasia (hazard ratio, 1.3; 95% CI, 1.2-1.5; P < .0001) and portal hypertension (hazard ratio, 1.4; 95% CI, 1.2-1.5; P < .0001) had lower survival.
conclusionsCVID-associated admissions with liver disease, particularly those with nodular regenerative hyperplasia and portal hypertension, were longer, more costly, and associated with increased mortality. Further studies are needed to improve early detection and long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.